Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 19;6(4):E544-E550.
doi: 10.9778/cmajo.20180063. Print 2018 Oct-Dec.

Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis

Affiliations

Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis

Ashra Kolhatkar et al. CMAJ Open. .

Abstract

Background: Out-of-pocket drug costs lead many Canadians to engage in cost-related nonadherence to prescription medications, but our understanding of other consequences such as borrowing money remains incomplete. In this descriptive study, we sought to quantify the frequency of borrowing to pay for prescription drugs in Canada and characteristics of Canadians who borrowed money for this purpose.

Methods: In partnership with Statistics Canada, we designed and administered a cross-sectional rapid-response module in the Canadian Community Health Survey administered by telephone to Canadians aged 12 years or more between January and June 2016. We restricted our analyses to participants who responded to the question regarding borrowing money to pay for prescription drugs and used logistic regression to identify characteristics associated with borrowing.

Results: A total of 28 091 Canadians responded to the survey (overall response rate 61.8%). The weighted proportion of respondents who reported having borrowed money to pay for prescription drugs in the previous year was 2.5% (95% confidence interval 2.2%-2.8%), an estimated 731 000 Canadians. The odds of borrowing were higher among younger adults, people in poor health and people lacking prescription drug insurance. Other factors associated with increased adjusted odds of borrowing were having 2 or more chronic conditions, low household income and higher out-of-pocket prescription drug costs.

Interpretation: Many Canadians reported borrowing money to pay for out-of-pocket prescription drug costs, and borrowing was more prevalent among already vulnerable groups that also report other compensatory behaviours to address challenges in paying for prescription drugs. Future research should investigate policy responses intended to increase equity in access to prescription drugs.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Michael Law has consulted for Health Canada and has acted as an expert witness for the Attorney General of Canada. Anne Holbrook is a therapeutics expert and drug policy consultant for the Ontario public drug programs, the Canadian Agency for Drugs and Technologies in Health and Hamilton hospitals. No other competing interests were declared.

Figures

Figure 1:
Figure 1:
Weighted proportion of respondents who reported having borrowed money to pay for prescription drugs in the previous year, by age (A), annual household income (B), prescription drug insurance plan (C) and annual out-of pocket-expenses on prescription drugs (D). “Total” bar indicates the estimated national rate of borrowing. Error bars indicate 95% confidence interval.

Similar articles

Cited by

References

    1. Daw JR, Morgan SG. Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010. Health Policy. 2012;104:19–26. - PMC - PubMed
    1. Kratzer J, McGrail K, Strumpf E, et al. Cost-control mechanisms in Canadian private drug plans. Healthc Policy. 2013;9:35–43. - PMC - PubMed
    1. National health expenditure trends, 1975 to 2016. Ottawa: Canadian Institute for Health Information; 2016.
    1. Hennessy D, Sanmartin C, Ronksley P, et al. Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease. Health Rep. 2016;27:3–8. - PubMed
    1. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22:864–71. - PMC - PubMed